Published in Endokrynol Pol on October 26, 1979
1,161 patients with adrenal incidentalomas: indications for surgery. Langenbecks Arch Surg (2007) 1.34
Incidentally discovered adrenal mass (incidentaloma): investigation and management of 208 patients. Clin Endocrinol (Oxf) (1997) 1.24
Incidentally discovered adrenal tumors: a lesson from observation of 1,444 patients. Horm Metab Res (2008) 1.10
Pituitary apoplexy: endocrine, surgical and oncological emergency. Incidence, clinical course and treatment with reference to 799 cases of pituitary adenomas. Acta Neurochir (Wien) (1993) 1.08
Low-molecular-weight heparins: pharmacologic profile and product differentiation. Am J Cardiol (1998) 0.99
Adrenocortical carcinoma. A clinical study and treatment results of 52 patients. Cancer (1995) 0.98
[Treatment of acromegaly by the surgical approach through the sphenoid bone. I. Clinical results]. Neurol Neurochir Pol (1983) 0.89
Molecular profiling and weight determination of heparins and depolymerized heparins. J Pharm Sci (1995) 0.89
Affinity purification of heparin-dependent antibodies to platelet factor 4 developed in heparin-induced thrombocytopenia: biological characteristics and effects on platelet activation. Br J Haematol (2000) 0.87
Decreased plasma dehydroepiandrosterone sulfate and dihydrotestosterone concentrations in young men after myocardial infarction. Atherosclerosis (1989) 0.86
[Antibodies directed against adrenal glands in Addison's and Cushing's diseases]. Pol Arch Med Wewn (1971) 0.86
Leptin and ghrelin concentrations and weight loss in Parkinson's disease. Acta Neurol Scand (2009) 0.85
Structural features and anticoagulant activities of a novel natural low molecular weight heparin from the shrimp Penaeus brasiliensis. Biochim Biophys Acta (1999) 0.85
Effect of DHEA supplementation on serum IGF-1, osteocalcin, and bone mineral density in postmenopausal, glucocorticoid-treated women. Adv Med Sci (2012) 0.85
Downregulation of clusterin expression in testicular germ cell tumours. Pathobiology (2001) 0.85
Ectopic ACTH syndrome due to bilateral ovarian androblastoma with double, gynandroblastic differentiation in one ovary. Eur J Obstet Gynecol Reprod Biol (1993) 0.84
Low molecular weight heparins: are they different? Can J Cardiol (1998) 0.83
The role of hyperinsulinemia in the development of lipid disturbances in nonobese and obese women with the polycystic ovary syndrome. J Endocrinol Invest (1991) 0.83
In vitro studies on the effect of activated protein C on platelet activation and thrombin generation. Thromb Res (1997) 0.82
The effect of metoclopramide, TRH and L-dopa on prolactin secretion in pituitary adenoma and in "functional" galactorrhoea syndrome. Acta Endocrinol (Copenh) (1979) 0.82
[Clinical significance of anti-tbyroid antibodies in Addison's disease]. Pol Tyg Lek (1978) 0.81
[Association of Addison's disease with hyperthyroidism]. Endokrynol Pol (1986) 0.81
Effect of clonidine on beta-endorphin, ACTH and cortisol secretion in essential hypertension and obesity. Eur J Clin Pharmacol (1988) 0.81
Nelson's syndrome -- 46 years later: clinical experience with 37 patients. Zentralbl Neurochir (2006) 0.81
[Radioimmunoassay of total serum thyroxine and triiodothyronine]. Endokrynol Pol (1977) 0.81
Comparative tissue factor pathway inhibitor release potential of heparins. Clin Appl Thromb Hemost (2005) 0.80
Transdermal 17 beta-estradiol combined with oral progestogen increases plasma levels of insulin-like growth factor-I in postmenopausal women. J Endocrinol Invest (1992) 0.80
TFPI antigen levels in normal human volunteers after intravenous and subcutaneous administration of unfractionated heparin and a low molecular weight heparin. Thromb Res (1995) 0.80
Comparative pharmacologic profile of a glycosaminoglycan mixture, Sulodexide, and a chemically modified heparin derivative, Suleparoide. Semin Thromb Hemost (1993) 0.79
Nelson's syndrome: incidence and prognosis. Clin Endocrinol (Oxf) (1983) 0.79
Chylothorax in infancy. Thorax (1968) 0.79
The role of tissue factor pathway inhibitor in the mediation of the antithrombotic actions of heparin and low-molecular-weight heparin. Blood Coagul Fibrinolysis (1995) 0.79
Serum prolactin responses to metoclopramide in Cushing's syndrome and Nelson's syndrome. Acta Endocrinol (Copenh) (1980) 0.79
Antithrombotic agents stimulate the synthesis and modify the sulfation pattern of a heparan sulfate proteoglycan from endothelial cells. Thromb Res (1994) 0.79
[Results of surgical treatment of 111 cases of adrenocortical hyperfunction (an analysis)]. Endokrynol Pol (1978) 0.78
The role of sex hormones in the mechanism of inhibited LH release in female patients with anorexia nervosa. Acta Endocrinol (Copenh) (1982) 0.78
Hyperinsulinaemia and decreased plasma levels of dehydroepiandrosterone sulfate in premenopausal women with coronary heart disease. J Intern Med (1995) 0.78
Comment of long-acting lanreotide inducing clinical and biochemical remission of acromegaly caused by disseminated GHRH secreting carcinoid. J Clin Endocrinol Metab (1999) 0.77
Preclinical studies on a low molecular weight heparin. Thromb Res (1996) 0.77
Cytostatics for acromegaly. Marked improvement in a patient with an invasive pituitary tumour. Acta Endocrinol (Copenh) (1987) 0.77
Physical and pharmacologic manipulation of the vascular system as measured by the release of TFPI and other mediators of antithrombotic actions. Int Angiol (1996) 0.77
Are the available low-molecular-weight heparin preparations the same? Semin Thromb Hemost (1996) 0.77
Enhanced testosterone in female patients with anorexia nervosa: its normalization after weight gain. Acta Endocrinol (Copenh) (1979) 0.77
Serum prolactin in women with premenstrual syndrome. Mater Med Pol (1982) 0.77
Anticoagulant and antithrombotic actions of a semisynthetic beta-1,3-glucan sulfate. Thromb Res (1995) 0.77
Antidiuretic effect of sulfonylureas in idiopathic diabetes insipidus. Helv Med Acta (1969) 0.76
Low molecular weight heparins: a developmental perspective. Expert Opin Investig Drugs (1997) 0.76
The role of endogenous opiates in the mechanism of inhibited luteinizing hormone (LH) secretion in women with anorexia nervosa: the effect of naloxone on LH, follicle-stimulating hormone, prolactin, and beta-endorphin secretion. J Clin Endocrinol Metab (1984) 0.76
[Serum concentration of triiodothyronine, thyroxine and thyrotropin in elderly]. Endokrynol Pol (1977) 0.76
Radioimmunological determination of exogenous corticotropin-releasing hormone (CRH) and growth hormone-releasing hormone (GHRH): plasma half-life of CRH and GHRH. Endokrynol Pol (1989) 0.76
Exaggerated growth hormone response to growth hormone-releasing hormone in type I diabetes mellitus. Acta Endocrinol (Copenh) (1988) 0.76
Inhibitory effects of TFPI on thrombin and factor Xa generation in vitro--modulatory action of glycosaminoglycans. Thromb Res (1994) 0.76
Enhancement of plasma corticotropin-releasing hormone in pregnancy-induced hypertension. Acta Endocrinol (Copenh) (1990) 0.76
Molecular profiling of heparinase-I resistant glycosaminoglycans in contaminated heparins. Comparative studies with uncontaminated heparin and porcine oversulfated chondroitin sulfate. Int Angiol (2008) 0.76
The effect of naloxone on ATCH and beta-endorphin in patients with Cushing's disease. Acta Endocrinol (Copenh) (1985) 0.76
Incidentally found adrenal tumours: results of investigation of the pituitary-adrenal axis. Endokrynol Pol (1992) 0.75
Cushing's syndrome in a 16-year-old girl due to ectopic ACTH precursor production from a pancreatic tumour. Clin Endocrinol (Oxf) (2001) 0.75
Inactivation of factor Xa by the synthetic inhibitor DX-9065a causes strong anticoagulant and antiplatelet actions in human blood. Blood Coagul Fibrinolysis (1999) 0.75
Management of Nelson's syndrome: observations in fifteen patients. Clin Endocrinol (Oxf) (2001) 0.75
Cushing's syndrome secondary to ectopic ACTH secretion from a primary ovarian carcinoma. Clin Endocrinol (Oxf) (1997) 0.75
The effect of oral ethanol ingestion on the diurnal neurotensin secretion in man. Endokrynol Pol (1992) 0.75
Methodologic basis for the radioimmunoassay of endogenous LH-like activity in human prostatic tissue. Nuklearmedizin (1983) 0.75
[Antidiuretic action of chlorpropamide in diabetes insipidus caused by vasopressin deficiency]. Pol Arch Med Wewn (1972) 0.75
[Excessive secretion of antidiuretic hormone (Schwartz-Bartter syndrome)]. Pol Arch Med Wewn (1971) 0.75
[Hypogonadotropinemia in women with Cushing's syndrome]. Endokrynol Pol (1980) 0.75
[Solid phase radioimmunoassay for human growth hormone]. Endokrynol Pol (1978) 0.75
Radioimmunological determination of beta-endorphin-like substance in human blood plasma and urine. Endokrynol Pol (1986) 0.75
[Treatment of the malignant phase of infiltrative-edematous exophthalmos in Graves-Basedow disease]. Pol Tyg Lek (1985) 0.75
[Diurnal rhythm of prolactin secretion in women with primary hypothyroidism]. Endokrynol Pol (1984) 0.75
[Effect of hypercalcemia on the secretion of insulin and anterior pituitary hormones]. Endokrynol Pol (1984) 0.75
Thyrotropin-releasing hormone (TRH) does not suppress growth hormone response to L-dopa in insulin-dependent diabetes mellitus. Endokrynol Pol (1992) 0.75
Evidence for alpha-adrenergic receptors mediated TSH release in men. Acta Endocrinol (Copenh) (1980) 0.75
[Prolactin secretion in patients with hyperthyroidism]. Pol Tyg Lek (1985) 0.75
[Effect of endogenous glucocorticosteroids on TRH-induced TSH secretion]. Endokrynol Pol (1978) 0.75
Effects of cyproheptadine and metyrapone on ACTH and aldosterone concentrations in patients with Cushing's disease: a preliminary report. Mater Med Pol (1982) 0.75
Lower 24-hour growth hormone levels in type I diabetics responding to thyrotropin-releasing hormone (TRH). Endokrynol Pol (1992) 0.75
[Mechanism of hormonal action mediated by cyclic 3', 5' AMP]. Pol Arch Med Wewn (1975) 0.75
[Role of hormonal disorders in the etiology of polycystic ovary syndrome (Stein-Leventhal syndrome)]. Endokrynol Pol (1982) 0.75
The effect of D-Trp6-LRH upon secretion of gonadotrophin--a possible therapeutic application in anorexia nervosa. Acta Endocrinol (Copenh) (1984) 0.75
[Increased reverse triiodothyronine concentration in anorexia nervosa]. Endokrynol Pol (1981) 0.75
[Effect of calcitonin on the secretion of PRL, TSH, GH, LH, FSH, cortisol, T3 and T4]. Endokrynol Pol (1984) 0.75
Effects of transdermal 17 beta-oestradiol combined with oral progestogen on lipids and lipoproteins in hypercholesterolaemic postmenopausal women. J Intern Med (1993) 0.75
[Hypothyroidism and pregnancy]. Pol Tyg Lek (1986) 0.75
[Hyperaldosteronism after metoclopramide administration]. Pol Arch Med Wewn (1980) 0.75
[Relationship between clinical classification of hyperthyroidism for three grades of severity and level of triiodothyronine (T3) and thyroxine (T4) concentrations in serum]. Endokrynol Pol (1992) 0.75
[Attempt at diagnosis of pituitary microadenomas as a cause of spontaneous hyperprolactinemia]. Endokrynol Pol (1981) 0.75
[Dissociation of the renin-angiotensin-aldosterone system in hyperthyroidism]. Pol Tyg Lek (1985) 0.75
Effect of insulin-induced hypoglycemia on plasma renin activity and aldosterone and cortisol concentration in humans. Endokrynol Pol (1986) 0.75
[Different hypogonadism mechanism in men and women suffering from Cushing's disease]. Endokrynol Pol (1981) 0.75
[Long-term inhibition of growth hormone secretion after alcohol intake. Disorders of physiological diurnal rhythm]. Pol Tyg Lek (1985) 0.75
[Effect of metoclopramide and acth on aldosterone secretion in patients with insufficiency of the anterior pituitary gland]. Pol Arch Med Wewn (1985) 0.75
The effect of naloxone on the secretion of pituitary hormones in patients with acromegaly, microprolactinomas, Cushing's disease and Nelson's syndrome. Endokrynol Pol (1986) 0.75
TRH-induced growth hormone release in insulin-dependent diabetes mellitus. Horm Metab Res (1984) 0.75
[Effect of synthetic LH-RH on the secretion of LM, FSH and testosterone in Stain-Leventhal syndrome]. Endokrynol Pol (1978) 0.75
[Diurnal rhythm of prolactin secretion after excessive intake of alcohol]. Endokrynol Pol (1984) 0.75